Methylcobalamin and Valacyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylcobalamin (vitamin b12) and Valacyclovir (valacyclovir hydrochloride). Common drug interactions include swelling face among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Methylcobalamin and Valacyclovir. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Methylcobalamin?

Methylcobalamin has active ingredients of vitamin b12. It is often used in vitamin b12 deficiency. eHealthMe is studying from 3,184 Methylcobalamin users. Check the latest studies of Methylcobalamin.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,107 Valacyclovir users. Check the latest studies of Valacyclovir.



On Jul, 27, 2026

56 people who take Methylcobalamin and Valacyclovir together, and have interactions are studied.

Methylcobalamin and Valacyclovir drug interactions.

What are the common drug interactions of Methylcobalamin and Valacyclovir, by gender? *:

female:

  1. Swelling face
  2. Tooth extraction
  3. Upper limb fracture
  4. Urticaria (rash of round, red welts on the skin that itch intensely)
  5. Vitiligo (pigment is lost from areas of the skin)
  6. Diarrhoea
  7. Hyperhidrosis (abnormally increased sweating)
  8. Pyrexia (fever)
  9. Dizziness
  10. Drug hypersensitivity

male:

  1. Pneumonia
  2. Tuberculous pleurisy (an inflammation of lung covering plura by mycobacterium tuberculosis)
  3. Pain in extremity
  4. Peripheral coldness
  5. Platelet count decreased
  6. Anaemia (lack of blood)
  7. Cytomegalovirus infection
  8. Death
  9. Decreased appetite
  10. Gastrointestinal infection (infection of stomach and intestine)

What are the common drug interactions of Methylcobalamin and Valacyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cytomegalovirus infection
  2. Gastrointestinal infection (infection of stomach and intestine)
  3. Large intestinal ulcer
  4. Allergy to animal
  5. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  6. Conjunctival hyperaemia (congestion of conjunctival vessels)
  7. Eye pruritus (eye itching)
  8. Facial paralysis (loss of function of face muscle)
  9. Haematochezia (passage of stools containing blood)
  10. Intraocular pressure increased

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hyperhidrosis (abnormally increased sweating)
  3. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  4. Blood pressure decreased
  5. Heart rate increased
  6. Oxygen saturation decreased
  7. Peripheral coldness
  8. Drug hypersensitivity
  9. Abdominal discomfort
  10. Abdominal pain

50-59:

  1. Abdominal pain
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Platelet count decreased
  5. Regurgitation (expulsion of material)
  6. Abdominal pain upper
  7. Anaemia (lack of blood)
  8. Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
  9. Death
  10. Diarrhoea

60+:

  1. Pneumonia
  2. Tuberculous pleurisy (an inflammation of lung covering plura by mycobacterium tuberculosis)
  3. Insomnia (sleeplessness)
  4. Pain in extremity
  5. Pyrexia (fever)
  6. Constipation
  7. Drug hypersensitivity
  8. Hypoxia (low oxygen in tissues)
  9. Intestinal obstruction
  10. Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 21 people, 37.50%
  2. High Blood Pressure: 11 people, 19.64%
  3. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 8 people, 14.29%
  4. Herpes Zoster: 7 people, 12.50%
  5. Productive Cough: 7 people, 12.50%
  6. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 7 people, 12.50%
  7. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 6 people, 10.71%
  8. Diarrhea: 6 people, 10.71%
  9. Cough: 6 people, 10.71%
  10. Blood Uric Acid Increased: 6 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Methylcobalamin and Valacyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methylcobalamin and Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylcobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylcobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vitamin b12 and valacyclovir hydrochloride (the active ingredients of Methylcobalamin and Valacyclovir, respectively), and Methylcobalamin and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: